Melodiol Global Health Limited (ME1.AX)
- Previous Close
0.0040 - Open
0.0030 - Bid 0.0030 x --
- Ask 0.0030 x --
- Day's Range
0.0030 - 0.0030 - 52 Week Range
0.0030 - 0.4400 - Volume
1,500,247 - Avg. Volume
8,141,774 - Market Cap (intraday)
845,610 - Beta (5Y Monthly) 2.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6000 - Earnings Date Feb 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser. In addition, the company develops Halucenex, which is in phase II clinical trials, which will test the efficacy of psilocybin on treatment of resistant Post Traumatic Stress Disorder. Further, it engages in marketing of its hemp based food, feed supplements, and topical products; manufacture and sale of packaged consumer products; conducts clinical trial and development of synthetic psilocybin micro and macro dose formulations to treat treatment resistant depression and anxiety; and development of psychedelic medicines. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
melodiolglobalhealth.com--
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: ME1.AX
Performance Overview: ME1.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ME1.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ME1.AX
Valuation Measures
Market Cap
8.76M
Enterprise Value
17.71M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.16
Price/Book (mrq)
--
Enterprise Value/Revenue
0.94
Enterprise Value/EBITDA
-0.71
Financial Highlights
Profitability and Income Statement
Profit Margin
-277.18%
Return on Assets (ttm)
-33.31%
Return on Equity (ttm)
-389.56%
Revenue (ttm)
18.92M
Net Income Avi to Common (ttm)
-35.52M
Diluted EPS (ttm)
-0.6000
Balance Sheet and Cash Flow
Total Cash (mrq)
692k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
8.37M
Company Insights: ME1.AX
ME1.AX does not have Company Insights